University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol

Not Applicable

Recruiting

Conditions: Secondhand Aerosol
Vaping
Hookah Smoking
Vascular Stiffness

Interventions: Other: Electronic Hookah Aerosol
Other: Combustible Hookah Smoke
Other: Clean Room Air

First Posted Date: 2020-12-10

Last Posted Date: 2023-11-29

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 12

Registration Number: NCT04661683

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Brain Imaging Biomarkers for Response to Spinal Cord Stimulation in Patients With Chronic Low Back Pain

Recruiting

Conditions: Chronic Low-back Pain

First Posted Date: 2020-12-08

Last Posted Date: 2023-12-07

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 42

Registration Number: NCT04658628

Locations: 🇺🇸
University of California Los Angeles, Los Angeles, California, United States

Telerehabilitation Early After Stroke

Not Applicable

Completed

Conditions: Stroke

Interventions: Device: Telerehabilitation

First Posted Date: 2020-12-08

Last Posted Date: 2023-04-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 19

Registration Number: NCT04657770

Locations: 🇺🇸
California Rehabilitation Institute, Los Angeles, California, United States
🇺🇸
Moss Rehabilitation Research Institute, Elkins Park, Pennsylvania, United States

Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)

Phase 4

Completed

Conditions: Pregnancy Related
Antepartum DVT

Interventions: Drug: Standard Dose of Unfractionated Heparin
Drug: Gestational Age-Based Dose of Unfractionated Heparin

First Posted Date: 2020-11-19

Last Posted Date: 2023-04-28

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 46

Registration Number: NCT04635839

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

Corneal Nerves After Treatment With Cenegermin

Active, not recruiting

Conditions: Neurotrophic Keratitis

Interventions: Drug: Cenegermin Ophthalmic Solution [Oxervate]

First Posted Date: 2020-11-13

Last Posted Date: 2024-11-27

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT04627571

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Mindfulness-based Intervention to Address PTSD in Trauma-exposed, Homeless Women

Not Applicable

Completed

Conditions: Hydrocortisone
Stress Disorders, Post-Traumatic
Substance Use
Depressive Symptoms

Interventions: Behavioral: Health Promotion Wellness Classes
Behavioral: Modified Mindfulness-based Stress Reduction

First Posted Date: 2020-10-27

Last Posted Date: 2023-11-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 158

Registration Number: NCT04605198

Locations: 🇺🇸
North County Serenity House, Escondido, California, United States
🇺🇸
Prototypes Women's Center, Pomona, California, United States

Promoting Resiliency in Veteran Families With Young Children

Not Applicable

Completed

Conditions: Depression
Regulation, Self
Trauma, Psychological
Stress Disorders, Traumatic
Emotional Stress
Anxiety
Stress, Psychological
Behavior, Child

Interventions: Behavioral: FOCUS-EC

First Posted Date: 2020-10-22

Last Posted Date: 2020-10-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 199

Registration Number: NCT04598100

LIFUP for Treatment of Motor Deficits in Parkinson's Disease

Not Applicable

Recruiting

Conditions: Parkinson Disease

Interventions: Device: Active LIFUP Treatment
Device: Sham LIFUP Treatment

First Posted Date: 2020-10-20

Last Posted Date: 2024-02-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT04593875

Locations: 🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

Angiotensin 2 for AKI After OLT

Phase 4

Conditions: Acute Kidney Injury
Cirrhosis, Liver
End Stage Liver DIsease
Liver Transplant; Complications

Interventions: Drug: Norepinephrine
Drug: Angiotensin II

First Posted Date: 2020-10-19

Last Posted Date: 2023-12-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 30

Registration Number: NCT04592744

Locations: 🇺🇸
Michael Y Lin, Los Angeles, California, United States

Quantifying Body Composition and Liver Disease in Children Using Free-Breathing MRI and MRE

Recruiting

Conditions: NASH - Nonalcoholic Steatohepatitis
NAFLD

Interventions: Diagnostic Test: Magnetic resonance imaging (MRI)
Diagnostic Test: Magnetic resonance elastography (MRE)
Device: Prototype MRE soft flexible passive transducer paddle

First Posted Date: 2020-10-19

Last Posted Date: 2023-11-21

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 190

Registration Number: NCT04591106

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy